Does CRISPR Therapeutics AG (CRSP) Pay a Dividend? (2026)
Short answer
CRISPR Therapeutics AG (CRSP) pays little or no dividend; like many growth-oriented companies it reinvests cash rather than paying income. A dividend is a slice of profits returned to shareholders, and the yield is that payout divided by the share price, so it drifts as both change. Figures here are approximate; verify the current number with your broker.
Does CRISPR Therapeutics AG (CRSP) pay a dividend?
CRISPR Therapeutics AG (CRSP) currently returns little or nothing as a dividend. Because CRISPR Therapeutics has no meaningful product profits yet, traditional earnings-based valuation multiples like P/E are negative and not analytically useful. The company is better evaluated on its cash runway, the pace of Casgevy's commercial adoption, and the risk-adjusted value of its pipeline. Enterprise value of roughly $2.8 billion (market cap less net cash) reflects the market pricing in significant execution uncertainty around both the Casgevy ramp and the broader pipeline, while a wide spread exists between bearish analyst targets near $33 and optimistic targets above $80.
How to think about CRSP's dividend
- Yield is a snapshot: minimal today, but it moves with price and payout.
- Total return vs income: dividends are one part of return; price change is usually the bigger part for a name like CRSP.
- Reinvest or take income: a DRIP compounds; taking the cash gives income now.
- For more yield: dedicated dividend stocks and ETFs target higher payouts. See the best dividend ETFs.
The bottom line on the CRSP dividend
CRISPR Therapeutics AG (CRSP) is not an income stock; if you own it, it is for growth or total return, not the dividend. For the full picture see the CRSP guide. Walnut can show how CRSP fits your real portfolio. It is not an investment adviser.
Build a basket around CRSP with Walnut
Use CRISPR Therapeutics AG as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Does CRISPR Therapeutics AG (CRSP) pay a dividend?
+
CRISPR Therapeutics AG (CRSP) pays little or no dividend; like many growth-stage companies it tends to reinvest cash rather than return it as income. Verify the current policy on CRSP's investor relations page.
What is CRSP's dividend yield?
+
CRSP's yield is minimal or zero. Companies prioritizing growth often pay no dividend and return cash through buybacks instead, if at all.
How often does CRSP pay its dividend?
+
US companies that pay dividends, like CRISPR Therapeutics AG if it does, typically distribute them quarterly. Confirm the exact schedule and ex-dividend dates on CRSP's investor relations page before relying on the timing.
Can I reinvest CRSP dividends?
+
Yes. Most brokers offer automatic dividend reinvestment (a DRIP) so any CRSP dividend buys more shares automatically. It compounds over time but is still taxable in a taxable account.
Is CRSP a good dividend stock?
+
Walnut is informational, not investment advice. CRSP is a growth or total-return name rather than an income stock. Dedicated dividend stocks and ETFs target higher, steadier yield; match the choice to whether you want income now or growth.
Does CRSP pay a dividend?
+
No. CRISPR Therapeutics does not pay a dividend. The company is pre-profitability with significant annual operating losses, and its capital is directed entirely toward clinical development and the commercial rollout of Casgevy. Investors seeking income from dividends would need to look elsewhere in the biotech or broader healthcare sector.
Walnut is informational, not investment advice. Dividend figures are approximate and dated; verify current yield, schedule, and policy with CRSP's investor relations page or your broker.